The role of cortisol in trust behavior: Results from an experimental study on healthy controls and patients with juvenile myoclonic epilepsy.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
09 2020
Historique:
received: 04 03 2020
revised: 23 04 2020
accepted: 24 04 2020
pubmed: 29 5 2020
medline: 18 3 2021
entrez: 29 5 2020
Statut: ppublish

Résumé

Trust is one of the foundations of human society and pervades all aspects of human live. Research on humans focused primarily on identifying the biological basis of trust behavior in healthy subjects, and this evidence hints to certain brain areas, hormones, and genetic factors to be fundamentally involved. The contribution of cortisol in trust has not yet elicited much attention in research, especially when specifically examined at basal cortisol levels. Trust has been previously studied in some neurological diseases but not in patients with epilepsy, and the influence of hormones on trust in these diseases remains yet unknown. Against this background, we designed an experimental study with a group of patients with juvenile myoclonic epilepsy and a group of healthy controls to compare trust behavior and plasma cortisol levels between the two groups. This economic game is frequently used in research to operationalize trust behavior. All participants further underwent neuropsychological assessment. Our results showed that there was no significant difference in trust behavior during the trust game, but a trend toward lower trust in patients. Furthermore, there was a significant difference in cortisol levels between groups with lower levels in patients. Interestingly, cortisol levels correlated with trust only in the patient group, but not in the control group. Future studies should specifically differentiate the effect of induced cortisol increases (e.g., acute stress) versus the effect of basal cortisol levels reflecting homeostasis or chronic stress on trust behavior and leverage the potential of comparison between patients and healthy controls.

Identifiants

pubmed: 32464541
pii: S1525-5050(20)30317-6
doi: 10.1016/j.yebeh.2020.107138
pii:
doi:

Substances chimiques

Biomarkers 0
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107138

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have declared that they have no conflicts of interest with respect to their authorship or the publication of this article.

Auteurs

Andrija Javor (A)

Department of Neurology 2, Kepler University Hospital, Med Campus III, Krankenhausstraße 7, 4021 Linz, Austria.

Laura Zamarian (L)

Department of Neurology, Innsbruck Medical University, Anichstraße 35, 6020 Innsbruck, Austria.

Gerhard Ransmayr (G)

Department of Neurology 2, Kepler University Hospital, Med Campus III, Krankenhausstraße 7, 4021 Linz, Austria.

Manuela Prieschl (M)

Department of Neurology, Innsbruck Medical University, Anichstraße 35, 6020 Innsbruck, Austria.

Melanie Bergmann (M)

Department of Neurology, Innsbruck Medical University, Anichstraße 35, 6020 Innsbruck, Austria.

Gerald Walser (G)

Department of Neurology, Innsbruck Medical University, Anichstraße 35, 6020 Innsbruck, Austria.

Gerhard Luef (G)

Department of Neurology, Innsbruck Medical University, Anichstraße 35, 6020 Innsbruck, Austria.

Wolfgang Prokop (W)

Central Institute for Medical and Chemical Laboratory Diagnosis, Innsbruck Medical University Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria.

Margarete Delazer (M)

Department of Neurology, Innsbruck Medical University, Anichstraße 35, 6020 Innsbruck, Austria.

Iris Unterberger (I)

Department of Neurology, Innsbruck Medical University, Anichstraße 35, 6020 Innsbruck, Austria. Electronic address: iris.unterberger@tirol-kliniken.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH